Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-046843

Chief Medical Officer gave up 1,395 shares (to pay taxes)

  • Chief Medical Officer acquired 2,812 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-04-14 Option exercise +2,812 30,930 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-04-14 Shares withheld for taxes −1,395 $5.64 $7,868 29,535 D
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-04-14 Option exercise · Restricted Stock Units −2,812 19,690 D
Loading xslF345X04/tm2313085-2_4seq1.xml…